Filing Details

Accession Number:
0000911916-16-000401
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-01-12 16:27:53
Reporting Period:
2016-01-08
Filing Date:
2016-01-12
Accepted Time:
2016-01-12 16:27:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1136869 Zimmer Biomet Holdings Inc. ZBH Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 134151777
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1239000 C David Dvorak C/O Zimmer, Inc.
P. O. Box 708
Warsaw IN 46580
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-01-08 20,464 $71.06 254,627 No 4 M Direct
Common Stock Disposition 2016-01-08 16,237 $102.71 238,390 No 4 S Direct
Common Stock Acquisiton 2016-01-08 34,536 $71.06 272,926 No 4 M Direct
Common Stock Disposition 2016-01-08 28,424 $102.32 244,502 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2016-01-08 20,464 $0.00 20,464 $71.06
Common Stock Employee Stock Option (right to buy) Disposition 2016-01-08 34,536 $0.00 34,536 $71.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
34,536 2016-01-18 No 4 M Direct
0 2016-01-18 No 4 M Direct
Footnotes
  1. Securities acquired pursuant to a written plan intended to comply with Rule 10b5-1(c)(1) adopted by Mr. Dvorak on September 4, 2015.
  2. Includes 162 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan between April 27, 2015 and November 2, 2015.
  3. Securities sold to cover option exercise cost, taxes and fess pursuant to a written plan intended to comply with Rule 10b5-1(c)(1) adopted by Mr. Dvorak on September 4, 2015.
  4. Represents the sale of 16,237 shares in multiple transactions, ranging in price from $102.20 to $103.04 per share, resulting in a weighted average sale price of $102.71. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
  5. Represents the sale of 28,424 shares in multiple transactions, ranging in price from $101.8301 to $102.65 per share, resulting in a weighted average sale price of $102.32. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
  6. Vested annually over four years in increments of 25% each year commencing on January 18, 2007.